United States Attorney David Metcalf announced today that Lehigh Valley Hospital Network, Inc. (LVHN) has agreed to pay $2,750,000 to resolve allegations that it failed to comply with provisions of the Controlled Substances Act (CSA) that are designed to prevent the diversion of controlled substances for illegal uses.
In particular, the settlement resolves LVHN’s disclosure to the United States that on approximately 40 occasions, a pharmacy technician at LVHN’s Cedar Crest pharmacy used another employee’s password to access, remove, and divert controlled substances, and created fictitious reports to hide the discrepancies of controlled substances. The settlement also resolves allegations that, at certain facilities, the controls and procedures that LVHN had in place failed to effectively guard against theft and diversion of controlled substances from its inpatient pharmacies to outpatient pharmacies and hospice facilities, resulting in the transfer of controlled substances between locations without proper documentation. LVHN also allegedly failed to maintain complete and accurate records of its stock of controlled substances.
Read Full Press Release
#HealthcareDiversion
#CivilCase